WE ARE LOOKING FORWARD TO SHARING SOME OF OUR RESULTS WITH THE SCIENTIFIC COMMUNITY,” COMMENTED DR. HYSLOP. “OUR TEAM OF BIOCHEMISTS, ORGANIC CHEMISTS, MOLECULAR BIOLOGISTS, GENETIC ENGINEERS, UNDERGRADUATE STUDENTS, AND GRADUATE STUDENTS CONTINUE TO WORK DILIGENTLY TO ACHIEVE OUR GOAL OF DEVELOPING TARGETED CANNABINOID-BASED CHEMOTHERAPY UTILIZING CELL-IN-A-BOX.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.